FI60201C - Analogifoerfarande foer framstaellning av 1-aryloxi-4-amino--2-butanoler med antiarytmisk aktivitet - Google Patents

Analogifoerfarande foer framstaellning av 1-aryloxi-4-amino--2-butanoler med antiarytmisk aktivitet Download PDF

Info

Publication number
FI60201C
FI60201C FI752966A FI752966A FI60201C FI 60201 C FI60201 C FI 60201C FI 752966 A FI752966 A FI 752966A FI 752966 A FI752966 A FI 752966A FI 60201 C FI60201 C FI 60201C
Authority
FI
Finland
Prior art keywords
phenyl
chloro
butanol
aryloxy
naphthyl
Prior art date
Application number
FI752966A
Other languages
English (en)
Finnish (fi)
Other versions
FI752966A7 (da
FI60201B (fi
Inventor
Carl Dalton Lunsford
Ying-Ho Chen
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of FI752966A7 publication Critical patent/FI752966A7/fi
Priority to FI803050A priority Critical patent/FI803050A7/fi
Application granted granted Critical
Publication of FI60201B publication Critical patent/FI60201B/fi
Publication of FI60201C publication Critical patent/FI60201C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
FI752966A 1974-10-25 1975-10-23 Analogifoerfarande foer framstaellning av 1-aryloxi-4-amino--2-butanoler med antiarytmisk aktivitet FI60201C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI803050A FI803050A7 (fi) 1974-10-25 1980-09-26 Nya 1-aryloxi-4-klor-2-butanoler vilka anvaends som mellanprodukter vid framstaellning av terapeutiskt vaerdefulla 1-aryloxi-4-klor-2-butanoler

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51812274A 1974-10-25 1974-10-25
US51812274 1974-10-25
US61898475A 1975-10-02 1975-10-02
US61898475 1975-10-02

Publications (3)

Publication Number Publication Date
FI752966A7 FI752966A7 (da) 1976-04-26
FI60201B FI60201B (fi) 1981-08-31
FI60201C true FI60201C (fi) 1981-12-10

Family

ID=27059352

Family Applications (1)

Application Number Title Priority Date Filing Date
FI752966A FI60201C (fi) 1974-10-25 1975-10-23 Analogifoerfarande foer framstaellning av 1-aryloxi-4-amino--2-butanoler med antiarytmisk aktivitet

Country Status (21)

Country Link
JP (1) JPS6023100B2 (da)
AU (1) AU507312B2 (da)
BR (1) BR7506930A (da)
CA (1) CA1077474A (da)
CH (1) CH612907A5 (da)
DE (1) DE2547570A1 (da)
DK (1) DK154288C (da)
ES (1) ES442077A1 (da)
FI (1) FI60201C (da)
FR (2) FR2289169A1 (da)
GB (1) GB1520931A (da)
HU (1) HU172525B (da)
IE (1) IE43402B1 (da)
IL (1) IL48309A (da)
IN (1) IN142736B (da)
NL (1) NL7512488A (da)
NO (1) NO142666C (da)
NZ (1) NZ178962A (da)
PH (2) PH16403A (da)
SE (2) SE434047B (da)
YU (1) YU39950B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779240B2 (ja) * 1987-12-11 1998-07-23 三井化学株式会社 新規アミン類およびその用途
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
DE2001431C3 (de) * 1970-01-06 1974-12-12 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben
HU169464B (da) * 1974-02-20 1976-11-28

Also Published As

Publication number Publication date
NO142666C (no) 1981-09-17
SE7511934L (sv) 1976-04-26
FR2289169A1 (fr) 1976-05-28
FI752966A7 (da) 1976-04-26
IL48309A (en) 1980-01-31
NO142666B (no) 1980-06-16
FR2361888A1 (fr) 1978-03-17
SE449357B (sv) 1987-04-27
JPS51131838A (en) 1976-11-16
CH612907A5 (en) 1979-08-31
FR2361888B1 (da) 1980-04-04
IL48309A0 (en) 1975-12-31
NO753575L (da) 1976-04-27
PH16403A (en) 1983-09-26
FI60201B (fi) 1981-08-31
DK154288B (da) 1988-10-31
YU269475A (en) 1982-02-28
AU8577875A (en) 1977-04-21
NZ178962A (en) 1978-03-06
PH16233A (en) 1983-08-11
SE7903894L (sv) 1979-05-04
HU172525B (hu) 1978-09-28
FR2289169B1 (da) 1980-05-30
IN142736B (da) 1977-08-20
DE2547570A1 (de) 1976-04-29
JPS6023100B2 (ja) 1985-06-05
IE43402B1 (en) 1981-02-25
IE43402L (en) 1976-04-25
NL7512488A (nl) 1976-04-27
AU507312B2 (en) 1980-02-14
DK480675A (da) 1976-04-26
DK154288C (da) 1989-03-28
BR7506930A (pt) 1976-08-17
SE434047B (sv) 1984-07-02
GB1520931A (en) 1978-08-09
YU39950B (en) 1985-06-30
CA1077474A (en) 1980-05-13
ES442077A1 (es) 1977-04-01

Similar Documents

Publication Publication Date Title
EP0159566B1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
PT88251B (pt) Processo para a preparacao de novos derivados de ariloxi-indenamina com actividade antidepressiva e de composicoes farmaceuticas que os contem
FI112649B (fi) Menetelmä terapeuttisesti käyttökelpoisten diamiiniyhdisteiden valmistamiseksi
DE2037852A1 (de) Neue Piperazindenvate und Ver fahren zu ihrer Herstellung
IE912492A1 (en) 1,4-disubstituted piperazines
FI63930C (fi) Foerfarande foer framstaellning av nya tertiaera aminoalkylfenyleterderivat anvaendbara som lokalanestetika
FI80448B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara piperazinkarboxamidderivat.
FI60201B (fi) Analogifoerfarande foer framstaellning av 1-aryloxi-4-amino-2-butanoler med antiarytmisk aktivitet
US4064245A (en) N-Phenoxyphenyl-piperazines
US4806555A (en) 1-aryloxy-4-amino-2-butanols
US2599001A (en) Nu, nu-disubstituted-beta-haloalkylamines
US4379167A (en) 1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
NO148451B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere.
FI78682C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara oximetrar.
US4463190A (en) 1-Aryloxy-4-amino-2-butanols
US2497394A (en) Alkylaminoalkyl benzoates
US4206217A (en) 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds
US2016480A (en) Perhydrocarbazyl compounds of the pyridine and quinoline series
US4333930A (en) Orthoarylideneaminophenethylamines and pharmaceutical compositions
McCarthy et al. New bicyclic antidepressant agent. Synthesis and activity of napactadine and related compounds
US3038901A (en) Phenylpiperazinylalkyl esters
PL177833B1 (pl) Pochodne triaryloetylenu i kompozycja farmaceutyczna zawierająca pochodne triaryloetylenu
HU178272B (en) Process for preparing new piperazino-methane-imino derivatives
US4066768A (en) Derivatives of 1-phenoxy-3-amino-propan-2-ol
FI77241B (fi) Nya cykliska iminderivat, deras tillverkning och farmaceutiska kompositioner innehaollande dessa.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: A.H. ROBINS COMPANY, INCORPORATED